Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001015966 | SCV001176864 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-03-26 | criteria provided, single submitter | clinical testing | The p.D855E variant (also known as c.2565C>A), located in coding exon 16 of the RAD50 gene, results from a C to A substitution at nucleotide position 2565. The aspartic acid at codon 855 is replaced by glutamic acid, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |